Bayer AG (BAYN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account
Sell

Buy

arrow-up€ (+%)

Bayer AG is active in the German healthcare sector. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and animal health products.
Prices updated at 01 May 2025, 18:27
| Prices minimum 15 mins delay
|
Prices in EUR

Most recent dividend payment

0.110
Cash Dividend
28 Apr 2025
31 Jan 2025
29 Apr 2025
30 Apr 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502.557.510

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.1100-
20240.1100-0.95
20232.40000.20
20222.0000-
20212.0000-0.29
20202.8000-
20192.80000.02
20182.75550.04
20172.65710.08
20162.46020.11

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20250.500.070.57
20240.57-0.57
20237.140.017.15
20224.14-4.14
20214.26-4.26
20205.81-5.81
20193.85-3.85
20184.55-4.55
20172.60-2.60
20162.52-2.52

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share202120222023202420250123

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)2021202220232024202502505007501000

Dividend per share data table

YearDividend per share
20250.1100
20240.1100
20232.4000
20222.0000
20212.0000
20202.8000
20192.8000
20182.7555
20172.6571
20162.4602

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025-
2024-
2023-
202241.84
2021869.57
2020-
2019-
201845.47
201755.82
201644.98
Latest Financial Report as of 30 Apr 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.